Jiangsu Kanion Pharmaceutical Co Ltd
SSE:600557

Watchlist Manager
Jiangsu Kanion Pharmaceutical Co Ltd Logo
Jiangsu Kanion Pharmaceutical Co Ltd
SSE:600557
Watchlist
Price: 14.1 CNY -0.21% Market Closed
Market Cap: 8.2B CNY
Have any thoughts about
Jiangsu Kanion Pharmaceutical Co Ltd?
Write Note
Jiangsu Kanion Pharmaceutical Co Ltd
/
Balance Sheet
/
Additional Paid In Capital

Jiangsu Kanion Pharmaceutical Co Ltd
Additional Paid In Capital

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Jiangsu Kanion Pharmaceutical Co Ltd
Additional Paid In Capital Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Additional Paid In Capital CAGR 3Y CAGR 5Y CAGR 10Y
Jiangsu Kanion Pharmaceutical Co Ltd
SSE:600557
Additional Paid In Capital
¥93m
CAGR 3-Years
-19%
CAGR 5-Years
-13%
CAGR 10-Years
-7%
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Additional Paid In Capital
¥14.1B
CAGR 3-Years
0%
CAGR 5-Years
61%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Additional Paid In Capital
¥1.1B
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
1%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Additional Paid In Capital
¥3.2B
CAGR 3-Years
-2%
CAGR 5-Years
14%
CAGR 10-Years
21%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Additional Paid In Capital
¥17.6B
CAGR 3-Years
-1%
CAGR 5-Years
0%
CAGR 10-Years
30%
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Additional Paid In Capital
¥858.7m
CAGR 3-Years
294%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Jiangsu Kanion Pharmaceutical Co Ltd
Glance View

Market Cap
8.2B CNY
Industry
Pharmaceuticals

In the bustling landscape of the Chinese pharmaceutical industry, Jiangsu Kanion Pharmaceutical Co Ltd emerges as a pivotal player, seamlessly blending centuries-old traditional Chinese medicine (TCM) with cutting-edge modern technology. Founded in 1975, the company has carved a niche for itself by focusing on the research, development, and production of both TCM and integrated Western medicine. Kanion is renowned for its innovative approach, transforming ancient herbal remedies into scientifically-backed therapeutic solutions. The company's approach is not just about preserving tradition but rather enhancing it, ensuring that products meet rigorous modern medical standards, thereby appealing to a broad spectrum of healthcare needs. Kanion generates revenue through a diversified portfolio spanning herbal medicines, biochemical drugs, and health supplements. By implementing modern R&D methodologies, the company supports its vast array of products with robust clinical research, catering to both domestic and international markets. One of their key revenue streams is prescription medicines sold in hospitals and clinics, complemented by over-the-counter products available in pharmacies. Additionally, Kanion's investment in strategic partnerships and technological advancements has opened pathways for export, further amplifying its financial success. Through this blend of tradition and innovation, Jiangsu Kanion Pharmaceutical Co Ltd has established a resilient business model that thrives on the growing global acceptance of combining Eastern and Western medicinal practices.

Intrinsic Value
23.97 CNY
Undervaluation 41%
Intrinsic Value
Price
What is Intrinsic Value?

See Also

What is Jiangsu Kanion Pharmaceutical Co Ltd's Additional Paid In Capital?
Additional Paid In Capital
93m CNY

Based on the financial report for Sep 30, 2024, Jiangsu Kanion Pharmaceutical Co Ltd's Additional Paid In Capital amounts to 93m CNY.

What is Jiangsu Kanion Pharmaceutical Co Ltd's Additional Paid In Capital growth rate?
Additional Paid In Capital CAGR 10Y
-7%

Over the last year, the Additional Paid In Capital growth was -24%. The average annual Additional Paid In Capital growth rates for Jiangsu Kanion Pharmaceutical Co Ltd have been -19% over the past three years , -13% over the past five years , and -7% over the past ten years .

Back to Top
ALPHA SPREAD
Follow us
Join more than 210,800+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.